Sign up for the Packaging Digest News & Insights newsletter.
January 30, 2014
1 Min Read
.svg?width=850&auto=webp&quality=95&format=jpg&disable=upscale "Covert marker technology")
Covert marker technology
The Food and Drug Administration issued draft guidance on July 13, 2009, covering the use of inks, pigments, flavors and other physical-chemical identifiers (PCIDs) by manufacturers to make drug products more difficult to duplicate by counterfeiters and to make it easier to identify the genuine version of the drug. The mark® On-Dose ID covert marker technology is a PCID that has been designed for application to solid oral-dose drug products. The draft guidance outlines regulatory filing requirements (NDA, ANDA and post-approval) for usage of the co.'s product markers for unit-level, on-dose authentication of solid oral-dose pharmaceuticals for the prevention of counterfeiting.ARmark Authentication Technologies, 717/227-5920.
You May Also Like
